NYSE:EVMN | Free Cash Flow | Evommune, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2024-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$27.5M$83,000.00-$27.59M
2025-12-31-$16.7M$104,000.00-$16.8M
2025-03-31-$23.9M$0.00-$23.9M
2024-12-31-$18.51M$0.00-$18.51M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$76.44M$235,000.00-$76.68M
2024-12-31-$58.2M$88,000.00-$58.28M